The Circadian–Melatonin Axis in Bone Remodeling: Receptor-Dependent Signaling, Receptor-Independent Actions, and Translational Constraints
Biomolecules · 2026
DOI: 10.3390/biom16091232 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Ching-Chieh Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, No. 168, Zhongxing Road, Longtan Dis…. Hauptthemen laut MEDLINE: Bone Remodeling, Melatonin, Circadian Rhythm. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taoyuan Armed Forces General Hospital.
Abstract (Originalsprache)
Bone remodeling is rhythmically regulated, yet the contribution of the circadian–melatonin axis to osteoporosis remains incompletely defined, in part because mechanistic findings obtained at high experimental concentrations are frequently extrapolated to physiological signaling. This narrative review examines that inference. PubMed/MEDLINE, Embase, Scopus, and Web of Science were searched from inception to July 2026 for English-language studies of melatonin, circadian clock genes, and bone; molecular, preclinical, epidemiological, and clinical evidence was appraised with attention to receptor dependence, exposure concentration, and study architecture. In osteoblast-lineage cells, melatonin promotes osteogenic differentiation through MT2-linked Wnt/β-catenin and MEK1/2–MEK5 signaling, post-translational stabilization of SP7, and modulation of the OPG/RANKL axis. By contrast, direct antiosteoclastic and antioxidant effects are usually reported at micromolar concentrations, four to six orders of magnitude above nocturnal plasma levels, and are increasingly attributable to receptor-independent chemistry converging on the ROS–KEAP1–NRF2 node shared with structurally unrelated antioxidant compounds. This exposure mismatch suggests that conventional oral doses engage receptor-mediated osteoblast pathways rather than reproduce high-dose antiresorptive effects; sustained exposure at or above 1 µM is not attainable by conventional oral administration, and the chronic safety of the doses that would be required has not been characterized. In humans, bone resorption has an intrinsic circadian rhythm, and night-shift work is associated with adverse skeletal outcomes, although causality remains unresolved. The five available randomized trials are small and heterogeneous; none was powered for fracture prevention, and none compared administration times for a skeletal endpoint. Melatonin therefore cannot currently be recommended for the treatment of osteoporosis. Human bone and marrow pharmacokinetics, receptor-specific in vivo dose–response experiments, and adequately powered monotherapy trials in established primary osteoporosis are the studies that would change this assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, No. 168, Zhongxing Road, Longtan District, Taoyuan City 325, Taiwan.
- School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 242062, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
- Department of Life Sciences, National Central University, Taoyuan 320, Taiwan.
- Division of Nephrology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
ORCID-Profile: Ching-Chieh Lin, Kuo-Cheng Lu
Förderung
- Taoyuan Armed Forces General Hospital
Zitieren
APA
Lin, C. C., Hou, Y. C., Hsiao, P. J., & Lu, K. C. (2026). The Circadian–Melatonin Axis in Bone Remodeling: Receptor-Dependent Signaling, Receptor-Independent Actions, and Translational Constraints. Biomolecules. https://doi.org/10.3390/biom16091232
Vancouver
Lin CC, Hou YC, Hsiao PJ, Lu KC. The Circadian–Melatonin Axis in Bone Remodeling: Receptor-Dependent Signaling, Receptor-Independent Actions, and Translational Constraints. Biomolecules. 2026. doi:10.3390/biom16091232
BibTeX
@article{Lin2026,
author = {Lin, Ching-Chieh and Hou, Yi-Chou and Hsiao, Po-Jen and Lu, Kuo-Cheng},
title = {The Circadian–Melatonin Axis in Bone Remodeling: Receptor-Dependent Signaling, Receptor-Independent Actions, and Translational Constraints},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16091232}
}
EUVIMED